Access divergence to new cancer medicines in the United Kingdom.

Autor: Lythgoe MP; Department of Surgery and Cancer, Imperial College London, London, UK. Electronic address: M.Lythgoe@imperial.ac.uk., Blagden S; Department of Oncology, University of Oxford, Oxford, UK., Stanway S; Royal Marsden Hospital, Sutton Surrey SM2 5PT, UK., Sullivan R; Institute of Cancer Policy, King's College London, London WC2R 2LS, UK.
Jazyk: angličtina
Zdroj: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Aug; Vol. 207, pp. 114131. Date of Electronic Publication: 2024 May 24.
DOI: 10.1016/j.ejca.2024.114131
Abstrakt: Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Databáze: MEDLINE